Philadelphia, PA4 Active Studies

Recurrent Pregnancy Loss Clinical Trials in Philadelphia, PA

Find 4 actively recruiting recurrent pregnancy loss clinical trials in Philadelphia, PA. Connect with local research sites and explore new treatment options.

4
Active Trials
2
Sponsors
523
Enrolling

Recruiting Recurrent Pregnancy Loss Studies in Philadelphia

NCT06712823Recruiting

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of atumelnant (CRN04894)....

Philadelphia, PAPHASE2200 participantsCrinetics Pharmaceuticals Inc.
View Study Details
NCT07159841Recruiting

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

The purpose of this study is to evaluate the safety, efficacy, pharmacokinetics (PK), and pharmacodynamics (PD) of atumelnant treatment in pediatric participants with classic congenital adrenal hyperp...

Philadelphia, PAPHASE2153 participantsCrinetics Pharmaceuticals Inc.
View Study Details
NCT07144163Recruiting

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

The purpose of this study is to evaluate the efficacy, safety, PK, and PD of atumelnant in adults with classic CAH due to 21-OHD....

Philadelphia, PAPHASE3150 participantsCrinetics Pharmaceuticals Inc.
View Study Details
NCT07536269Recruiting

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

The main objective of this study is to assess the safety and tolerability of crinecerfont in pediatric participants 3 months to \<4 years of age with CAH....

Philadelphia, PAPHASE220 participantsNeurocrine Switzerland GmbH
View Study Details

About Recurrent Pregnancy Loss Clinical Trials in Philadelphia

Recurrent pregnancy loss is defined as two or more failed pregnancies and affects about 1-2% of couples trying to conceive. Causes include chromosomal abnormalities, uterine anomalies, and immune factors. Treatment depends on the underlying cause and may include hormonal support, surgery, or immunotherapy.

There are currently 4 recurrent pregnancy loss clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 523 participants. Research is being sponsored by Crinetics Pharmaceuticals Inc., Neurocrine Switzerland GmbH. Clinical trial participation is free and participants receive study-related medical care at no cost.

Recurrent Pregnancy Loss Clinical Trials in Philadelphia — FAQ

Are there recurrent pregnancy loss clinical trials in Philadelphia?

Yes, there are 4 recurrent pregnancy loss clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What recurrent pregnancy loss treatments are being tested?

The 4 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for recurrent pregnancy loss.

Data updated October 15, 2026 from ClinicalTrials.gov